Trials / Completed
CompletedNCT02583828
Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Capital Medical University · Academic / Other
- Sex
- Female
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized clinical trial to investigate the efficacy of letrozole combined with metronomic oral cyclophosphamide in elderly metastasis breast cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclophosphamide 50mg | |
| DRUG | Letrozole 2.5 mg |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2020-12-01
- Completion
- 2021-12-01
- First posted
- 2015-10-22
- Last updated
- 2024-02-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02583828. Inclusion in this directory is not an endorsement.